SACUBITRIL; VALSARTAN | A213682 | ALEMBIC PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc., et al 1 patentANDA 213682, 213605, 213748, 213646, 213671sacubitril/valsartan | D. Del. | 2022-10-24 | Terminated 2025-07-11 | — |
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al 4 patentsANDA 213682sacubitril/valsartan | D. Del. | 2020-01-17 | Terminated 2024-02-07 | — |
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al 4 patentsANDA 213682, 213728, 213689sacubitril/valsartan | D. Del. | 2019-10-24 | Terminated 2025-07-17 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.